Scandinavian ChemoTech Valuation
| CMOTEC-B | SEK 1.21 0.02 1.68% |
Today, the company appears to be overvalued. Scandinavian ChemoTech has a current Real Value of kr1.1 per share. The regular price of the company is kr1.21. Our model measures the value of Scandinavian ChemoTech from inspecting the company fundamentals such as Shares Owned By Insiders of 26.03 %, current valuation of 68.38 M, and Return On Equity of -1.17 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Scandinavian ChemoTech's price fluctuation is extremely dangerous at this time. Calculation of the real value of Scandinavian ChemoTech is based on 3 months time horizon. Increasing Scandinavian ChemoTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Scandinavian ChemoTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Scandinavian Stock. However, Scandinavian ChemoTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.21 | Real 1.1 | Hype 1.21 | Naive 1.04 |
The real value of Scandinavian Stock, also known as its intrinsic value, is the underlying worth of Scandinavian ChemoTech Company, which is reflected in its stock price. It is based on Scandinavian ChemoTech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Scandinavian ChemoTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Scandinavian ChemoTech AB helps investors to forecast how Scandinavian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Scandinavian ChemoTech more accurately as focusing exclusively on Scandinavian ChemoTech's fundamentals will not take into account other important factors: Scandinavian ChemoTech Total Value Analysis
Scandinavian ChemoTech AB is currently forecasted to have takeover price of 68.38 M with market capitalization of 113.35 M, debt of 53 K, and cash on hands of 5.62 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Scandinavian ChemoTech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
68.38 M | 113.35 M | 53 K | 5.62 M |
Scandinavian ChemoTech Investor Information
About 26.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.19. Scandinavian ChemoTech had not issued any dividends in recent years. The entity had 1061:839 split on the 20th of April 2020. Scandinavian ChemoTech AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.Scandinavian ChemoTech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Scandinavian ChemoTech has an asset utilization ratio of 0.19 percent. This suggests that the Company is making kr0.001898 for each dollar of assets. An increasing asset utilization means that Scandinavian ChemoTech AB is more efficient with each dollar of assets it utilizes for everyday operations.Scandinavian ChemoTech Ownership Allocation
The market capitalization of Scandinavian ChemoTech is kr113.35 Million. Scandinavian ChemoTech maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Scandinavian ChemoTech Profitability Analysis
The company reported the revenue of 49 K. Net Loss for the year was (17.74 M) with profit before overhead, payroll, taxes, and interest of 2.86 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Scandinavian ChemoTech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Scandinavian ChemoTech and how it compares across the competition.
About Scandinavian ChemoTech Valuation
The stock valuation mechanism determines Scandinavian ChemoTech's current worth on a weekly basis. Our valuation model uses a comparative analysis of Scandinavian ChemoTech. We calculate exposure to Scandinavian ChemoTech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Scandinavian ChemoTech's related companies.Scandinavian ChemoTech AB provides cancer care and pain management solutions. Scandinavian ChemoTech AB is headquartered in Malmo, Sweden. Scandinavian ChemoTech is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Scandinavian ChemoTech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Scandinavian ChemoTech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Scandinavian ChemoTech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Scandinavian ChemoTech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Scandinavian ChemoTech's revenue streams: Identify Scandinavian ChemoTech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Scandinavian ChemoTech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Scandinavian ChemoTech's growth potential: Evaluate Scandinavian ChemoTech's management, business model, and growth potential.
- Determine Scandinavian ChemoTech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Scandinavian ChemoTech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Scandinavian Stock analysis
When running Scandinavian ChemoTech's price analysis, check to measure Scandinavian ChemoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandinavian ChemoTech is operating at the current time. Most of Scandinavian ChemoTech's value examination focuses on studying past and present price action to predict the probability of Scandinavian ChemoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandinavian ChemoTech's price. Additionally, you may evaluate how the addition of Scandinavian ChemoTech to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |